Members of the CARE Liver Disease Faculty recently attended the AASLD conference held in San Francisco, California (November 13-17). The CARE Perspectives Conference Report from AASLD 2015 provides a summary of the most compelling stories and news presented at this event, and is augmented with additional perspectives from the CARE Liver Disease Faculty. While AASLD covers a number of different types of liver diseases, the focus of this report is on hepatitis C (HCV). Advances in HCV research and drug development over the last few years have provided potentially curative therapy options for many patients. Moving forward, the goal will be to continue to improve on the identification of HCV in Canada (45% of population remain undiagnosed) so that patients can receive necessary treatment. In doing so, this could significantly reduce the risk of disease progression and in some cases provide a cure. While data for future combinations is very promising, access to currently available, highly effective regimens warrants attention as there are a subset of patients that need to be treated now.
The CARE Liver Disease Faculty looks forward to pursuing these considerations further and providing continued medical education in this exciting medical field. The content that follows is written in the language in which it was presented. The following content is adapted from the most up-to-date presentations made at the AASLD 2015 meeting, and is augmented with content and perspectives from the CARE Liver Disease Faculty